Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xingshun Qi, Weirong Ren, Yongji Wang, Xiaozhong Guo & Daiming Fan. (2015) Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies. Expert Review of Gastroenterology & Hepatology 9:6, pages 865-875.
Read now
Read now
Susana Seijo & Juan Carlos Garcia-Pagan. (2014) An overview of current treatment methods for Budd–Chiari syndrome. Expert Opinion on Orphan Drugs 2:2, pages 147-157.
Read now
Read now
Shailendra Kapoor. (2013) Cardiac surgery: a rare and often overlooked cause of Budd–Chiari syndrome. Scandinavian Journal of Gastroenterology 48:8, pages 989-990.
Read now
Read now
Feifei Lu, Siqi Jia, Huiyuan Lu, Haonan Zhao, Zhe Li, Yuzheng Zhuge, Fernando Gomes Romeiro, Nahum Mendez-Sanchez & Xingshun Qi. Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review. Current Medical Research and Opinion 0:0, pages 1-24.
Read now
Read now
Articles from other publishers (40)
Özgür Özen, Fatih Boyvat, Çağrı Kesim, Tolga Zeydanlı & Pelin Kaya. (2023) Percutaneous revision of dysfunctional shunts in patients who underwent intrahepatic portosystemic shunt procedure via percutaneous or conventional method: 11-years single center experience. Irish Journal of Medical Science (1971 -) 192:6, pages 2755-2761.
Crossref
Crossref
Pankaj Puri & Sarthak Malik. (2023) Liver Transplantation: Contraindication and Ineligibility. Journal of Clinical and Experimental Hepatology 13:6, pages 1116-1129.
Crossref
Crossref
Alexandra Shingina, Nizar Mukhtar, Jamilé Wakim-Fleming, Saleh Alqahtani, Robert J. Wong, Berkeley N. Limketkai, Anne M. Larson & Lafaine Grant. (2023) Acute Liver Failure Guidelines. American Journal of Gastroenterology 118:7, pages 1128-1153.
Crossref
Crossref
Martin Rössle. (2023) Interventional Treatment of Budd–Chiari Syndrome. Diagnostics 13:8, pages 1458.
Crossref
Crossref
Sai Swarupa Reddy Vulasala, Nirmal Kumar Reddy Onteddu, Sanjeeva Prasad Kalva & Sara Smolinski-Zhao. (2022) Expanding Indications of TIPS in the Management of Portal Hypertension Complications. Journal of Clinical Interventional Radiology ISVIR 07:01, pages 034-045.
Crossref
Crossref
Mihnea-Alexandru Găman, Matei-Alexandru Cozma, Muhammad Romail Manan, Bahadar S Srichawla, Arkadeep Dhali, Sajjad Ali, Ahmed Nahian, Andrew C Elton, LV Simhachalam Kutikuppala, Richard Christian Suteja, Sebastian Diebel, Amelia Maria Găman & Camelia Cristina Diaconu. (2023) Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature. World Journal of Clinical Oncology 14:3, pages 99-116.
Crossref
Crossref
Yong Lv, Daiming Fan & Guohong Han. (2022) Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China. Liver International 43:1, pages 18-33.
Crossref
Crossref
Xuefeng Luo, Oana Nicoară-Farcău, Marta Magaz, Fabian Betancourt, Guillem Soy, Anna Baiges, Fanny Turon, Virginia Hernández-Gea & Juan Carlos García-Pagán. 2023. Cardio-Hepatology. Cardio-Hepatology
65
92
.
Ege Sinan Torun, Mert Erciyestepe, Yasemin Yalçınkaya, Ahmet Gül, Murat İnanç, Lale Öcal, Sabahattin Kaymakoğlu, Bora Peynircioğlu & Bahar Artım-Esen. (2022) A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt. Clinical Medicine Insights: Case Reports 15, pages 117954762211005.
Crossref
Crossref
Sern Wei Yeoh & Hong Kuan Kok. (2021) Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. Journal of Digestive Diseases 22:9, pages 506-519.
Crossref
Crossref
Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sundeep Punamiya, Valerie Paradis, Xingshun Qi, Yasuhiko Sugawara, Zaigham Abbas & Shiv Kumar Sarin. (2021) Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 15:3, pages 531-567.
Crossref
Crossref
Sajad Ahmad Salati. (2020) Transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome. Clinical Surgery Research Communications 4:3, pages 25-26.
Crossref
Crossref
Riccardo Inchingolo, Alessandro Posa, Martin Mariappan, Tiago Kojun Tibana, Thiago Franchi Nunes, Stavros Spiliopoulos & Elias Brountzos. (2020) Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review. World Journal of Gastroenterology 26:34, pages 5060-5073.
Crossref
Crossref
Kursat Rahmi Serin, Yaman Tekant & Ali Emre. (2020) Is There Still a Role for Surgical Shunts in the Treatment of Budd-Chiari Syndrome? A 25-Year Experience. Journal of Gastrointestinal Surgery 24:6, pages 1359-1365.
Crossref
Crossref
Lina I. Arcila-Garcés, José D. Correa-Vargas, Camila Guerrero-Bermúdez & Mariana Vélez-Marín. (2020) Manejo de pacientes con síndrome de Budd-Chiari. Revisión de tema. Hepatología, pages 55-67.
Crossref
Crossref
Qiuhe Wang, Kai Li, Xulong Yuan, Bohan Luo & Guohong Han. (2019) Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy – Authors' reply. The Lancet Gastroenterology & Hepatology 4:11, pages 823-824.
Crossref
Crossref
Qiuhe Wang, Kai Li, Chuangye He, Xulong Yuan, Bohan Luo, Xingshun Qi, Wengang Guo, Wei Bai, Tianlei Yu, Jiahao Fan, Zhengyu Wang, Jie Yuan, Xiaomei Li, Ying Zhu, Na Han, Jing Niu, Yong Lv, Lei Liu, Jing Li, Shihao Tang, Shuai Guo, Enxing Wang, Dongdong Xia, Zhexuan Wang, Hongwei Cai, Jianhong Wang, Zhanxin Yin, Jielai Xia, Daiming Fan & Guohong Han. (2019) Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial. The Lancet Gastroenterology & Hepatology 4:9, pages 686-697.
Crossref
Crossref
Faisal Khan, Matthew J. Armstrong, Homoyon Mehrzad, Frederick Chen, Desley Neil, Rachel Brown, Owen Cain & Dhiraj Tripathi. (2019) Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Alimentary Pharmacology & Therapeutics 49:7, pages 840-863.
Crossref
Crossref
Faisal Khan, Homoyon Mehrzad & Dhiraj Tripathi. (2018) Timing of transjugular intrahepatic portosystemic stent-shunt in Budd–Chiari syndrome: A UK hepatologist's perspective. Journal of Translational Internal Medicine 6:3, pages 97-104.
Crossref
Crossref
Qiuhe Wang & Guohong Han. (2017) Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdominal Radiology 43:8, pages 1908-1919.
Crossref
Crossref
Shalimar, Shivanand R. Gamanagatti, Arpan H. Patel, Saurabh Kedia, Baibaswata Nayak, Deepak Gunjan, Gyan Ranjan, Shashi B. Paul & Subrat K. Acharya. (2017) Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd–Chiari syndrome. European Journal of Gastroenterology & Hepatology 29:10, pages 1174-1182.
Crossref
Crossref
Christopher R. Reilly, Daria V. Babushok, Karlyn Martin, Jerry L. Spivak, Michael Streiff, Ranjeeta Bahirwani, Jeffrey Mondschein, Brady Stein, Alison Moliterno & Elizabeth O. Hexner. (2017) Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. American Journal of Hematology 92:9, pages 909-914.
Crossref
Crossref
Georges HayekMaxime RonotAurélie PlessierAnnie SibertMohamed Abdel-RehimMagaly ZappaPierre-Emmanuel RautouDominique VallaValérie Vilgrain. (2017) Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology 283:1, pages 280-292.
Crossref
Crossref
. (2017) Diagnosis and treatment guidelines for aberrant portal hemodynamics. Hepatology Research 47:5, pages 373-386.
Crossref
Crossref
Masaaki Hidaka & Susumu Eguchi. (2017) Budd-Chiari syndrome: Focus on surgical treatment. Hepatology Research 47:2, pages 142-148.
Crossref
Crossref
Fuliang He, Hongwei Zhao, Shan Dai, Yingfeng Wu, Lei Wang, Hongdong Huang, Zhendong Yue, Zhenhua Fan, Xiaoqun Dong & Fuquan Liu. (2016) Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins. Scientific Reports 6:1.
Crossref
Crossref
Mitchell Smith & Janette Durham. (2016) Evolving Indications for Tips. Techniques in Vascular and Interventional Radiology 19:1, pages 36-41.
Crossref
Crossref
Sean R. Dariushnia, Ziv J Haskal, Mehran Midia, Louis G. Martin, T. Gregory Walker, Sanjeeva P. Kalva, Timothy W.I. Clark, Suvranu Ganguli, Venkataramu Krishnamurthy, Cindy K. Saiter & Boris Nikolic. (2016) Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts. Journal of Vascular and Interventional Radiology 27:1, pages 1-7.
Crossref
Crossref
Rishi M Goel, Emma L Johnston, Kamal V Patel & Terence Wong. (2015) Budd–Chiari syndrome: investigation, treatment and outcomes. Postgraduate Medical Journal 91:1082, pages 692-697.
Crossref
Crossref
Zachary L. Bercu, Sachin B. Sheth, Amir Noor, Robert A. Lookstein, Aaron M. Fischman, F. Scott Nowakowski, Edward Kim & Rahul S. Patel. (2014) Percutaneous Mesocaval Shunt Creation in a Patient with Chronic Portal and Superior Mesenteric Vein Thrombosis. CardioVascular and Interventional Radiology 38:5, pages 1316-1319.
Crossref
Crossref
Xingshun Qi, Jia Jia, Ming Bai, Xiaozhong Guo, Chunping Su, Juan C. García-Pagán, Guohong Han & Daiming Fan. (2015) Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding. Journal of Clinical Gastroenterology 49:6, pages 495-505.
Crossref
Crossref
Zachary L. BercuAaron M. FischmanEdward KimF. Scott NowakowskiRahul S. PatelThomas D. SchianoCharissa Y. ChangRobert A. Lookstein. (2015) TIPS for Refractory Ascites: A 6-Year Single-Center Experience With Expanded Polytetrafluoroethylene–Covered Stent-Grafts. American Journal of Roentgenology 204:3, pages 654-661.
Crossref
Crossref
Fu-Liang He. (2015) Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World Journal of Gastroenterology 21:8, pages 2413.
Crossref
Crossref
Edna Strauss & Dominique Valla. (2014) Non-cirrhotic portal hypertension – Concept, diagnosis and clinical management. Clinics and Research in Hepatology and Gastroenterology 38:5, pages 564-569.
Crossref
Crossref
Xingshun Qi, Daiming Fan & Guohong Han. (2014) Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: Still an open issue. Liver International 34:8, pages 1288-1289.
Crossref
Crossref
Xingshun Qi, Wengang Guo, Chuangye He, Wei Zhang, Feifei Wu, Zhanxin Yin, Ming Bai, Jing Niu, Zhiping Yang, Daiming Fan & Guohong Han. (2014) Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver International 34:8, pages 1164-1175.
Crossref
Crossref
X. Qi, D. Fan & G. Han. (2014) Letter: transjugular intrahepatic portosystemic shunt for the treatment of Budd–Chiari syndrome in China. Alimentary Pharmacology & Therapeutics 39:12, pages 1437-1438.
Crossref
Crossref
Richard Parker. (2014) Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Clinics in Liver Disease 18:2, pages 319-334.
Crossref
Crossref
Xingshun Qi, Lei Liu, Ming Bai, Hui Chen, Juan Wang, Zhiping Yang, Guohong Han & Daiming Fan. (2014) Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: A meta-analysis. Journal of Gastroenterology and Hepatology 29:4, pages 688-696.
Crossref
Crossref
Xing-Shun Qi. (2014) Selection of treatment modalities for Budd-Chiari Syndrome in China: A preliminary survey of published literature. World Journal of Gastroenterology 20:30, pages 10628.
Crossref
Crossref